The Science Isn’t Settled on Chronic Lyme
Vermont has one of the highest rates of Lyme disease in the U.S.
An article in Slate magazine says the controversial diagnosis of chronic Lyme Disease should be taken more seriously by the medical community.
The report, The Science Isn’t Settled on Chronic Lyme, by Maya Dusenbery and Julie Rehmeyer appeared on the Slate website on June 27.
Here is an interesting excerpt:
None of this is settled science, of course. But that’s rather the point: The skeptics act as though the science is already settled, when in actuality, patients are suffering desperately for lack of science.
* * *
The main reason we don’t have answers to those questions yet is that we’ve barely tried to find them. “If the same number of researchers were working on HIV as Lyme disease, we’d still have no treatment for HIV,” says John Aucott of Johns Hopkins. In 2017, the NIH spent $22 million on Lyme disease research; by contrast, Congress appropriated $1.1 billion to study and fight the Zika virus just a year after it first emerged. This lack of investment is likely to cost us dearly as climate change continues to cause ticks and their pathogens to spread: a disease that first drew attention only in a small area of Connecticut is now spreading worldwide and becoming an epidemic. And the attitude of ridicule for chronic Lyme is part of why we don’t bother to research it.